Professional Documents
Culture Documents
Dr. Maria Wolfs Assistant Professor Endocrinology and Metabolism St. Michaels Hospital
Outline
Case discussions
DM in hospitalized patients
Approximately 1 in 4 patients admitted to the hospital has a known diagnosis of diabetes 30% of patients with diabetes require >2 hospitalizations in any given year High prevalence of diabetes elderly patients residents of long-term-care facilities
up
Perioperative hyperglycemia
Perioperative hyperglycemia
postoperative infections
2.7
times higher in patients with glucose > 12.2 mmol/liter than in those with glucose levels below 12.2 mmol/liter
glucose value above 8.3 mmol/liter associated with increased length of stay, hospital complications, and postoperative mortality
Infection
RR 0.41 (0.21- 0.71)
dose should be reduced if glucose levels are between 3.9 mmol/liter and 5.6 mmol/L
Provided that their medical conditions, dietary intake and glycemic control are acceptable, patients with diabetes should be maintained on their prehospitalization oral antihyperglycemic agents or insulin regimens [Grade D, Consensus]. Perioperative glycemic levels should be maintained between 5.0 and 11.0 mmol/L for most other surgical situations, with an appropriate protocol and trained staff to ensure the safe and effective implementation of this therapy and minimize the likelihood of hypoglycemia [Grade D, Consensus].
Outline
Case discussions
Case #1
1000mg bid Gliclazide MR 60mg am Humulin N 20u hs Atorvastatin 10mg hs Perindopril 8mg
Case #2
29M MVC multiple fractures and head injury Type 1 DM since age 4 Medications
Humalog
On call to OR
Case #3
75M POD2 bowel obstruction Type 2 DM x 10 years A1c 7.6% Medications at home
Metformin
Case #4
58F scheduled for total thyroidectomy for multinodular goitre Type 2 DM for 10 years A1c 7.3% Metformin 1g bid Humulin Mix 25 60-0-40-0
Case #5
78M POD 5 hip fracture ORIF Type 2 diabetes Metformin 1000mg BID Glyburide 10mg BID Continuous NG feeds - swallowing concerns BS on oral meds 14-18 mmol/L
Approach to perioperative DM
The Patient
Type 1 or Type 2
Type
Diet
NPO,
The Treatment
Agents
Metformin
Concern
Lactic acidosis
Stop if:
CHF, renal insufficiency (eGFR <30ml/min), hypoperfusion, or chronic pulmonary disease, at risk of developing renal failure and lactic acidosis, iv contrast dye NPO, reduce dose if diet reduced
Sulfonylurea
NPO
Agents
Sitagliptin (Januvia) Saxagliptin (Onglyza) Linagliptin (Trajenta ) Pioglitazone (Actos) Rosiglitazone (Avandia)
Concern
Renal impairment: Sita eGFR <50 Saxa 2.5mg if eGRF 15-30 Lina approved in ESRD Causes CHF Rosi increased CV mortality Bladder CA Atypical fractures GI upset
Stop if:
NPO
Alphaglucosidase inhibitor
Acarbose
Insulin 101
BOLUS 60%
TDD = total daily dose of insulin BASAL insulin = 40% of TDD BOLUS insulin = 60% TDD
BASAL 40%
Insulin 101
TDD = total daily dose of insulin BASAL insulin = 40% of TDD BOLUS insulin = 60% TDD
Insulin 101
TDD = total daily dose of insulin BASAL insulin = 40% of TDD BOLUS insulin = 60% TDD
Insulin 101
BOLUS 60%
BASAL 40%
Insulin pharmacokinetics
Humulin BOLUS BASAL Humalog Regular N Humalog Mix 25 Humulin 30/70 PUMP Novolin Novorapid Toronto NPH Levemir Novomix 30 Novolin 30/70 Sanofi Apidra Lantus Onset (h) 0.25-0.5 0.5 2 2 2 Peak (h) 1-2 2-3 6-8 Duration (h) 3 4-6 12-20 16-20 20-24
MIXED
Insulin pharmacokinetics
Humulin BOLUS BASAL Humalog Regular N Humalog Mix 25 Humulin 30/70 PUMP Novolin Novorapid Toronto NPH Levemir Novomix 30 Novolin 30/70 Sanofi Apidra Lantus Onset (h) 0.25-0.5 0.5 2 2 2 Peak (h) 1-2 2-3 6-8 Duration (h) 3 4-6 12-20 16-20 20-24
MIXED
Usual DM regimen Oral agents only Oral agents + bedtime N Oral agents + bedtime Lantus or Levemir Mixed insulin BID MDI with bedtime N MDI with am and bedtime N MDI with Lantus or Levemir Insulin pump
Basal insulin
Humulin BASAL N Novolin NPH Levemir Sanofi Lantus Onset (h) 2 2 2 Peak (h) 6-8 Duration (h) 12-20 16-20 20-24
Subcutaneous N/NPH
40%
100% HS
Intravenous drip
7 40
IV insulin infusion
Check for institutions pre-printed order set 1. Order insulin concentration
IV insulin infusion
Check for institutions pre-printed order set 1. Order insulin concentration
2.
Order IV fluids
IV insulin infusion
Check for institutions pre-printed order set 1. Order insulin concentration
2.
Order IV fluids
3.
Home regimen Oral agents only Oral agents + bedtime insulin Mixed insulin BID MDI
24
1.0 units/hour
40
1.5 units/hour
7.2 20
C Yu Jan 2012
IV insulin infusion
Check for institutions pre-printed order set 1. Order insulin concentration
2.
Order IV fluids
3. 4.
IV insulin infusion
Check for institutions pre-printed order set 1. Order insulin concentration
2.
Order IV fluids
3. 4.
Correction factor
70M home insulin regimen Humulin 30/70 30-0-20-0 TDD = ___ units
Correction factor
70M home insulin regimen Humulin 30/70 30-0-20-0 TDD = 50 units CF = 100/TDD = 100/50 =___
Correction factor
70M home insulin regimen Humulin 30/70 30-0-20-0 TDD = 50 units CF = 100/TDD = 100/50 = 2 1 unit of insulin will lower BG by 2 mmol/L
Correction factor
60 F home insulin regimen Humulin 30/70 Humalog 6-5-8-0 + Glargine 14 hs TDD = ___ units CF = 100/TDD = 100/___ = ___ 1 unit of insulin will lower BG by ___ mmol/L
Correction factor
60 F home insulin regimen Humulin 30/70 Humalog 6-5-8-0 + Glargine 14 hs TDD = 33 units CF = 100/TDD = 100/33 = 3 1 unit of insulin will lower BG by 3 mmol/L
Target a BG of 6 mmol/L Start at 6+CF e.g. if TDD = 50 then CF = 2 then 6+2= ___
Blood glucose (mmol/L) 4.0-8.0 8.1-10.0 10.1-12.0 12.1-14.0 14.1-16.0 16.1-18.0 18.1-20.0 > 20.1
Target a BG of 6 mmol/L Start at 6+CF e.g. if TDD = 33 then CF = ___ then 6+__=__
Blood glucose (mmol/L) 4.0-9.0 9.1-12.0 12.1-15.0 15.1-18.0 18.1-21.0 > 21.0
Give additional bolus of: Give amp D5W, check BG in 15 min, call MD Continue at current rate 1 unit = 10 cc and continue at current rate 2 unit = 20 cc and continue at current rate Correction factor 3 unit = 30 cc and continue at current rate 4 unit = 40 cc and continue at current rate 5 unit = 50 cc, call MD
If additional bolus required for 2 consecutive hours, increase infusion rate by 0.5 u/hr = 5 cc/hr May need to adjust If no additional bolus required for 2 consecutive hours, decrease capillary blood glucose check to q4h
C Yu Jan 2012
The Surgery
The Surgery
Procedure
Procedure Major cardiovascular Likely post-op ICU Day surgery OR <2 hours DM regimen IV insulin drip IV insulin drip Ensure basal coverage until eating Ensure basal coverage until eating
The Surgery
Procedure Timing
Timing Morning case Afternoon Unknown Ensure adequate basal Adequate basal or IV insulin drip DM regimen
Plan to eat
The Surgery
Outline
Case discussions
Case #1
1000mg bid Gliclazide MR 60mg am Humulin N 20u hs Atorvastatin 10mg hs Perindopril 8mg
The Patient
Type 1 or Type 2
Type
Diet
NPO,
The Treatment
Agents
Metformin
Concern
Stop if:
CHF, renal insufficiency (eGFR <30ml/min), hypoperfusion, or chronic pulmonary disease, at risk of developing renal failure and lactic acidosis, iv contrast dye NPO, reduce dose if diet reduced
Lactic acidosis
Sulfonylurea
NPO
The Surgery
Write orders
Blood glucose (mmol/L) 4.0-8.0 8.1-10.0 10.1-12.0 12.1-14.0 14.1-16.0 16.1-18.0 18.1-20.0 > 20.1
Case #2
29M MVC multiple fractures and head injury Type 1 DM since age 4 Medications
Humalog
On call to OR
The Patient
Type 1 or Type 2
Type
Diet
NPO,
The Treatment
The Surgery
Write orders
Either calculate basal from TDD or use Lantus dose = 12 units/day Insulin drip rate = basal rate/24 hours
12
Blood glucose (mmol/L) 4.0-9.0 9.1-12.0 12.1-15.0 15.1-18.0 18.1-21.0 > 21.0
Case #3
Case #3
75M POD2 bowel obstruction Type 2 DM x 10 years A1c 7.6% Medications at home
Metformin
Poor appetite post-op only minimal clear fluids Blood sugars 13-18 mmol/L Baseline eGFR >60ml/min Cr 95 Postop Cr 150
Case #3
Restart metformin + sitagliptin Restart metformin + gliclazide + sitagliptin Start sliding scale Start IV insulin drip Start basal insulin Start basal insulin + correction factor
Agents
Metformin
Concern
Lactic acidosis
Stop if:
CHF, renal insufficiency (eGFR <30ml/min), hypoperfusion, or chronic pulmonary disease, at risk of developing renal failure and lactic acidosis, iv contrast dye NPO, reduce dose if diet reduced
Sulfonylurea
NPO
Agents
Sitagliptin (Januvia) Saxagliptin (Onglyza) Linagliptin (Trajenta ) Pioglitazone (Actos) Rosiglitazone (Avandia)
Concern
Renal impairment: Sita eGFR <50 Saxa 2.5mg if eGRF 15-30 Lina approved in ESRD
Stop if:
NPO
Alphaglucosidase inhibitor
Acarbose
Write orders
Subcutaneous N/NPH
40%
HS
Intravenous drip
Case #3
Blood glucose (mmol/L) 4.0-9.0 9.1-12.0 12.1-15.0 15.1-18.0 18.1-21.0 > 21.0
Case #3
Breakfast Blood sugar Humulin N Humalog Correction 12.4 5 +2 Lunch 10.1 +1 Dinner 13.6 +2 Bedtime 8.9 7 0
Required 5 units of Humalog correction Can increase basal insulin by 4 units Humulin N 7 units AM 9 units HS
Case #3
oral medications
If
Cr remains high
Add
Bolus insulin
Case #4
58F scheduled for total thyroidectomy for multinodular goitre Type 2 DM for 10 years A1c 7.3% Metformin 1g bid Humulin Mix 25 60-0-40-0
Write orders
Blood glucose (mmol/L) 4.0-8.0 8.1-10.0 10.1-12.0 12.1-14.0 14.1-16.0 16.1-18.0 18.1-20.0 > 20.1
Case #5
78M POD 5 hip fracture ORIF Type 2 diabetes Metformin 1000mg BID Glyburide 10mg BID Continuous NG feeds - swallowing concerns BS on oral meds 14-18 mmol/L
Write orders
Case #5
Blood glucose (mmol/L) 4.0-9.0 9.1-12.0 12.1-15.0 15.1-18.0 18.1-21.0 > 21.0
Case #5
06:00 Blood sugar Metformin + Glyburide Humalog Correction
12:00 15.7 9 9 +3
18:00 16.1 9 9 +3
00:00 13.5 9 9 +2
15.3 9 9 +3
N 3-3-3-3 OR
Increase
CF to 1:2
Outline
Case discussions